Clinical Trials in Maryland

Showing 9201-9220 of 23,284 trials

Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation

NCT04035200

The purpose of this study is to evaluate the safety, tolerability and efficacy of V117957 in subjects with alcohol use disorder (AUD) who experience insomnia associated with alcohol cessation, compared to placebo.

Insomnia

Imbrium Therapeutics114 participantsStarted Sep 2019

Glendale, California, United States • Riverside, California, United States • San Diego, California, United States +14 more locations

COMPLETEDPhase 314 miles

Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease

NCT02760433

The purpose of this study was to determine how effective and safe the study drug Olokizumab was in patients with Rheumatoid Arthritis (RA) who had been already receiving, but not fully responding to treatment with an existing medication called a tumour necrosis factor alpha inhibitor The primary objective of this study was to evaluate the efficacy of olokizumab (OKZ) 64 mg administered subcutaneously (SC) once every 2 weeks (q2w) or once every 4 weeks (q4w) relative to placebo in subjects with moderately to severely active rheumatoid arthritis (RA) inadequately controlled by TNF-α inhibitor (TNFi) therapy.

Rheumatoid Arthritis

R-Pharm International, LLC368 participantsStarted Jan 2017

Phoenix, Arizona, United States • Hot Springs, Arkansas, United States • Covina, California, United States +113 more locations

Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation

Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease

Find Trials by Condition in Maryland

Blood Volume Assessment in COVID-19 and Bacterial Sepsis

A Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems (SPY-PHI) in the Visualization of Lymphatic Vessels and Identification of Lymph Nodes During Sentinel Lymph Node Biopsy in Subjects With Breast Cancer

Single Escalating Dose Pilot Trial of Canakinumab (ILARIS®) in Duchenne Muscular Dystrophy

SNS and PrEP Initiation and Adherence in Black SMM

Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.

A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors

Impact of Fever Prevention in Brain Injured Patients

Subchondroplasty® Knee RCT

A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD

MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram

Human Epilepsy Project 2: Resistant Focal Seizures Study

A Dose-escalation Study to Evaluate the Safety and Clinical Activity of PBCAR269A, With or Without Nirogacestat, in Study Participants With Relapsed/Refractory Multiple Myeloma

A Study of BTX-1188 in Subjects With Advanced Malignancies

Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients

Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses

Pilot Study of Multi-wavelength Laser for Tattoo Removal

A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination